TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate October 1, 1976